| Association between expression level of PD1 by tumor-infiltrating CD8+ T cells and features of hepatocellular carcinoma HD Kim, GW Song, S Park, MK Jung, MH Kim, HJ Kang, C Yoo, K Yi, ... Gastroenterology 155 (6), 1936-1950. e17, 2018 | 245 | 2018 |
| VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers CG Kim, M Jang, Y Kim, G Leem, KH Kim, H Lee, TS Kim, SJ Choi, ... Science immunology 4 (41), eaay0555, 2019 | 166 | 2019 |
| Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival HD Kim, YS Lim, S Han, J An, GA Kim, SY Kim, SJ Lee, HJ Won, JH Byun Gastroenterology 148 (7), 1371-1382, 2015 | 128 | 2015 |
| Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach TH Kim, IH Kim, SJ Kang, M Choi, BH Kim, BW Eom, BJ Kim, BH Min, ... Journal of Gastric Cancer 23 (1), 3, 2023 | 87 | 2023 |
| 4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8+ T Cells in Hepatocellular Carcinoma HD Kim, S Park, S Jeong, YJ Lee, H Lee, CG Kim, KH Kim, SM Hong, ... Hepatology 71 (3), 955-971, 2020 | 83 | 2020 |
| Lenvatinib versus Sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: an inverse probability of treatment weighting analysis A Casadei‐Gardini, M Scartozzi, T Tada, C Yoo, S Shimose, G Masi, ... Liver International 41 (6), 1389-1397, 2021 | 51 | 2021 |
| TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer HS Han, S Jeong, H Kim, HD Kim, AR Kim, M Kwon, SH Park, CG Woo, ... Cancer letters 499, 137-147, 2021 | 49 | 2021 |
| Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma S Chuah, J Lee, Y Song, HD Kim, M Wasser, NA Kaya, K Bang, YJ Lee, ... Journal of hepatology 77 (3), 683-694, 2022 | 47 | 2022 |
| PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15 KH Kim, HK Kim, HD Kim, CG Kim, H Lee, JW Han, SJ Choi, S Jeong, ... Cellular & Molecular Immunology 18 (2), 385-397, 2021 | 44 | 2021 |
| Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: a multicentre retrospective study HD Kim, Y Bang, MA Lee, JW Kim, JH Kim, HJ Chon, B Kang, MJ Kang, ... Liver International 40 (10), 2544-2552, 2020 | 42 | 2020 |
| Tumor volume doubling time as a dynamic prognostic marker for patients with hepatocellular carcinoma JK Kim, HD Kim, MJ Jun, SC Yun, JH Shim, HC Lee, D Lee, J An, YS Lim, ... Digestive diseases and sciences 62, 2923-2931, 2017 | 42 | 2017 |
| Novel anti-4-1BB× PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade S Jeong, E Park, HD Kim, E Sung, H Kim, J Jeon, Y Kim, U Jung, YG Son, ... Journal for Immunotherapy of Cancer 9 (7), 2021 | 28 | 2021 |
| Immunological and clinical implications of immune checkpoint blockade in human cancer HD Kim, SH Park Archives of pharmacal research 42, 567-581, 2019 | 28 | 2019 |
| Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer BS Kim, DS Kuen, CH Koh, HD Kim, SH Chang, S Kim, YK Jeon, YJ Park, ... Journal for immunotherapy of cancer 9 (6), 2021 | 25 | 2021 |
| Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization HD Kim, JH Shim, GA Kim, YM Shin, E Yu, SG Lee, D Lee, KM Kim, ... Journal of Hepatology 62 (5), 1076-1084, 2015 | 23 | 2015 |
| Implication of CD69+CD103+ tissue‐resident‐like CD8+ T cells as a potential immunotherapeutic target for cholangiocarcinoma HD Kim, S Jeong, S Park, YJ Lee, YS Ju, D Kim, GW Song, JH Lee, ... Liver International 41 (4), 764-776, 2021 | 22 | 2021 |
| Reference interval for thyrotropin in a ultrasonography screened Korean population M Kim, TY Kim, SH Kim, Y Lee, S Park, HD Kim, H Kwon, YM Choi, ... The Korean Journal of Internal Medicine 30 (3), 335, 2015 | 22 | 2015 |
| Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients SM Son, CG Woo, DH Kim, HY Yun, H Kim, HK Kim, Y Yang, J Kwon, ... Scientific Reports 10 (1), 14293, 2020 | 21 | 2020 |
| Prognostic stratification of patients with Burkitt lymphoma using serum β2-microglobulin levels HD Kim, H Cho, S Kim, K Lee, EH Kang, JS Park, CS Park, J Huh, JS Ryu, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2021 | 14 | 2021 |
| Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis A Casadei-Gardini, L Rimassa, M Rimini, C Yoo, BY Ryoo, S Lonardi, ... Journal of Cancer Research and Clinical Oncology, 1-7, 2021 | 14 | 2021 |
Changhoon YooAsan Medical Center, University of Ulsan College of Medicineamc.seoul.kr의 이메일 확인됨
